The optimal use of PEG-Asparaginase in relapsed ALL—lessons from the ALLR3 Clinical Trial
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology
Link
http://www.nature.com/articles/bcj201426.pdf
Reference15 articles.
1. Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV et al. Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial. Lancet 2010; 376: 2009–2017.
2. Messinger YH, Gaynon PS, Sposto R, van der Giessen J, Eckroth E, Malvar J et al. Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukaemia: therapeutic advances in childhood leukaemia & lymphoma (TACL) study. Blood 2012; 120: 285–290.
3. Pieters R, Hunger SP, Boos J, Rizzari C, Silverman L, Baruchel A et al. L-asparaginase treatment in acute lymphoblastic leukaemia: a focus on Erwinia asparaginase. Cancer 2011; 117: 238–249.
4. Kelly ME, Lu X, Devidas M, Camitta B, Abshire T, Bernstein ML et al. Treatment of relapsed precursor-B acute lymphoblastic leukaemia with intensive chemotherapy: POG (Pediatric Oncology Group) study 9411 (SIMAL 9). J Pediatr Hematol Oncol 2013; 35: 509–513.
5. Vora A, Goulden N, Wade R, Mitchell C, Hancock J, Hough R et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. Lancet Oncol 2013; 14: 199–209.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. l-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review;Medical Oncology;2023-04-15
2. Activity and toxicity of intramuscular 1000 iu /m 2 polyethylene glycol‐ E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials;British Journal of Haematology;2022-03-29
3. l-asparaginase-induced biochemical toxicities in young adults with acute lymphoblastic leukaemia and T-lymphoblastic lymphoma;Pathology;2021-12
4. Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia—a report from the UKALL 2011 trial;European Journal of Cancer;2019-10
5. Drug Delivery in Cancer Therapy, Quo Vadis?;Molecular Pharmaceutics;2018-03-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3